Bladder Cancer
Immune checkpoint‑targeted cancer immunotherapies.
February 19, 2016
Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec
February 19, 2016
Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy
February 18, 2016
Pictorial review of orthotopic neobladder reconstruction: indication, normal postsurgical anatomy, and complications
February 18, 2016
Mycobacterium phlei cell wall-nucleic acid complex in the treatment of nonmuscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin
February 18, 2016
Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis
February 18, 2016
David J. McConkey, Ph.D., Named Director of the Johns Hopkins Greenberg Bladder Cancer Institute
February 16, 2016
A Review Comparing Experience and Results with Bipolar Versus Monopolar Resection for Treatment of Bladder Tumors
February 16, 2016
Oncologic surveillance in bladder cancer following radical cystectomy: A systematic review and meta-analysis
February 16, 2016
Pretreatment levels of serum osteoprotegerin and p53 protein and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients
February 16, 2016
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer
February 15, 2016
Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer
February 15, 2016
A chronic care ostomy self-management program for cancer survivors
February 12, 2016
Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems
February 12, 2016